The vulnerability could allow attackers to execute arbitrary commands and steal credentials and other secrets. A critical sandbox escape vulnerability in the n8n AI workflow automation platform could ...

Multiple critical vulnerabilities in the popular n8n open-source workflow automation platform allow escaping the confines of the environment and taking complete control of the host server.

Strip the types and hotwire the HTML—and triple check your package security while you are at it. JavaScript in 2026 is just getting started. I am loath to inform you that the first month of 2026 has ...

A JavaScript sandbox bug rated CVSS 9.9 enables attackers to bypass AST‑based protections, while a Python execution bypass affects internal‑mode deployments common in enterprise setups. Two critical ...

Charter carrier JSX operates a hop-on jet service. Photo Credit: LorenzATX/Shutterstock JetBlue is ending its decade-long loyalty program partnership with scheduled charter carrier JSX. The last day ...

Starting tomorrow, December 19, 2025, commercial aviation will return to Santa Monica, California (SMO), when JSX commences flights to Las Vegas (LAS). But, just a day before that service starts, JSX ...

A critical vulnerability in the popular expr-eval JavaScript library, with over 800,000 weekly downloads on NPM, can be exploited to execute code remotely through maliciously crafted input. The ...

Instant experiences on the web have become more of a requirement than a preference. The performance of React applications depends heavily on JavaScript bundle size ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Will you have to pay taxes on your Social Security income? It ...

If you purchase an independently reviewed product or service through a link on our website, Variety may receive an affiliate commission. Air carrier JSX is now flying to Napa, just in time for harvest ...

A comparative study of the real-world safety and effectiveness of metronomic cyclophosphamide and bevacizumab with or without pembrolizumab for recurrent ovarian cancer. This is an ASCO Meeting ...

KEYNOTE-859: 4.5-year median follow-up of pembrolizumab plus chemotherapy for previously untreated advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. This is an ASCO ...